Can You Put Iodine in Your Nose?

Diluted povidone-iodine can be applied inside the nose, and researchers have been studying nasal formulations for years in the context of surgical infection prevention, respiratory viruses, and chronic sinus disease. The key word is “diluted.” Pure iodine tincture or full-strength surgical scrub solution would damage the delicate lining of your nasal passages. Lab studies consistently show that low-concentration povidone-iodine destroys a wide range of pathogens on contact, but clinical trials in real people have produced messier, more ambiguous results than the petri-dish data might lead you to expect.

Why Povidone-Iodine and Not Plain Iodine

When people ask about “putting iodine in the nose,” they almost always mean povidone-iodine, a complex in which iodine molecules are bound to a polymer called polyvinylpyrrolidone. That carrier slowly releases small amounts of free iodine, which is the component that actually kills pathogens. The slow release is what makes the formulation tolerable on living tissue. Full-strength tincture of iodine or Lugol’s solution would cause chemical burns to the thin mucous membrane that lines the inside of your nose. Povidone-iodine, by contrast, has been used as a wound and skin antiseptic for over six decades, with a broad spectrum of activity against viruses, bacteria, and fungi and no documented microbial resistance.¹

Even within the povidone-iodine family, concentration makes a huge difference. The brown bottle of Betadine you might have in your medicine cabinet is typically a 10 percent solution. That is far too strong for your nasal passages. The formulations studied for nasal use range from about 0.4 percent up to 2.5 percent, with most research clustering around 0.5 to 1.25 percent. Getting this wrong matters, and we will come back to what higher concentrations do to the cells lining your nose.

What the Lab Studies Show

In a controlled lab setting, povidone-iodine is remarkably effective at killing SARS-CoV-2. At concentrations of 0.5, 1.25, and 2.5 percent, nasal antiseptic formulations completely inactivated the virus within 15 seconds of contact.² A separate lab study confirmed that various concentrations of povidone-iodine nasal and oral antiseptics completely inactivated the virus after 60 seconds of exposure.³

Those results sound dramatic, and they are. The problem is that a petri dish is not a nose. In the lab, you control exactly how much solution contacts how much virus for exactly how long. Inside a living nasal cavity, the solution gets diluted by mucus, washed away by natural drainage, and may not reach every mucosal fold where virus is replicating. That gap between lab efficacy and real-world performance turned out to be a recurring theme.

What Happens When People Actually Use It

Clinical trials of nasal povidone-iodine have produced a genuinely mixed bag. A Phase II trial using a 0.5 percent spray found that treated subjects had significantly better viral-load reduction over the first few days compared to placebo, with complete nasal and throat clearance of viable SARS-CoV-2 by day five.⁴ That sounds promising, and it was one of the more optimistic results in the literature.

Other trials were less encouraging. A randomized controlled trial that combined povidone-iodine mouthwash, gargle, and nasal spray found that the treatment had no meaningful influence on changes in viral RNA levels over time, even though a one-day snapshot suggested a larger relative drop in viral titers in the treatment group.⁵ And a pilot study testing a 0.4 percent spray found poor virucidal activity: at three minutes after application, about two-thirds of patients showed some reduction in viral titers, but by four hours, viral levels had barely changed from baseline in most cases. The researchers concluded this concentration was unlikely to reduce transmission.⁶

The most recent large trial looked at povidone-iodine nasal spray for the common cold rather than COVID-19 specifically. In the full group of 260 adults, Nasodine showed only a modest and statistically non-significant benefit over saline spray for nasal symptoms. But in subgroups who started treatment within 24 hours of symptom onset, the benefit on overall symptom scores jumped to roughly 40 percent. People who had confirmed viral infections and stronger initial symptoms also fared better on the spray than on saline.⁷ The pattern across multiple trials suggests that timing and severity at baseline may matter a great deal. If the virus has already established itself deeply, squirting antiseptic into the front of the nose may be too little too late.

Where Nasal Iodine Has Stronger Evidence: Surgical Decolonization

The most established medical use for nasal povidone-iodine is not fighting respiratory viruses but preventing surgical infections. Many people carry Staphylococcus aureus bacteria in their nostrils without knowing it. If those bacteria hitch a ride into a surgical wound, they can cause serious infections. Wiping out nasal Staph before an operation is called decolonization, and hospitals have been doing it for years using an antibiotic ointment called mupirocin. Povidone-iodine has been studied as an alternative because it works quickly and does not contribute to antibiotic resistance.

A randomized trial found that a single application of a povidone-iodine-based nasal antiseptic before surgery eliminated Staph aureus in more than two-thirds of patients.⁸ A pediatric hospital that implemented universal preoperative nasal povidone-iodine for high-risk surgeries saw Staph aureus surgical-site infection rates drop from 1.3 per 100 procedures to zero.⁹ The approach has been gaining traction as a promising option for preoperative decontamination, particularly because it avoids the resistance concerns that come with antibiotic-based protocols.¹⁰

This surgical context is worth knowing about because it accounts for much of the safety data that exists on nasal povidone-iodine. The confidence researchers have about short-term nasal use comes largely from studies on preoperative patients, where outcomes are tracked carefully and adverse effects are well documented.

The Concentration Question and Your Nasal Lining

The inside of your nose is lined with ciliated epithelium: tiny hair-like structures that beat rhythmically to move mucus and trapped particles toward the throat. Anything you spray into your nose interacts with those cilia, and concentration is the dividing line between safe and damaging.

A purpose-built nasal formulation (0.5 percent povidone-iodine) tested on human nasal epithelial cells showed no toxicity, no disruption to the barrier function between cells, and no harm to ciliary beat frequency.¹¹ A safety review covering multiple studies concluded that concentrations below 2.5 percent do not reduce ciliary beat frequency or cause pathological changes to the nasal lining, and that povidone-iodine has been safely administered in the nasal cavity for up to five months at these concentrations.¹²

Go higher and the picture changes fast. Undiluted 10 percent Betadine and 5 percent Betadine both stopped ciliary activity entirely within a minute in one lab study. The researchers specifically cautioned against applying standard Betadine solution to respiratory mucosal surfaces.¹³ Even the 2 percent concentration, while not directly ciliotoxic, caused a high rate of nasal burning in one clinical trial, which is a practical reason to stick with lower concentrations.¹⁴

This is why diluting a bottle of Betadine at home is risky. Getting from 10 percent down to 0.5 percent requires a 20-fold dilution, and inaccurate measuring could easily leave you with a solution strong enough to damage your nasal lining. Purpose-formulated nasal sprays are manufactured at the intended concentration and buffered for mucosal compatibility, which is a meaningful difference from a kitchen-sink dilution.

Thyroid Concerns

Iodine is absorbed through mucous membranes, and your thyroid gland is exquisitely sensitive to iodine levels. This raises a natural worry: could spraying iodine into your nose disrupt your thyroid? The existing data is reassuring for short-term use at low concentrations. A safety review found that chronic mucosal use of povidone-iodine at concentrations up to 5 percent has not been shown to result in clinical thyroid disease.¹² A study of povidone-iodine applied during childbirth found that maternal urinary iodine roughly doubled after application but neonatal thyroid hormone levels were unaffected.¹⁵

That said, clinical trials of nasal povidone-iodine consistently exclude people with known thyroid disease.⁷ If you have hyperthyroidism, hypothyroidism, Graves’ disease, or Hashimoto’s thyroiditis, nasal iodine products are not for you without explicit clearance from your doctor. The safety reassurance applies to people with normal thyroid function.

Who Should Stay Away From It

The exclusion criteria from clinical trials offer a useful list of who should not casually try nasal povidone-iodine. Beyond thyroid disease, trials have excluded people with:

Iodine sensitivity: True iodine allergy is rare, but when it occurs, even low-concentration nasal exposure can trigger reactions.
Pregnancy or breastfeeding: The iodine absorbed through mucous membranes could theoretically affect fetal or infant thyroid development.
Chronic respiratory conditions: People with asthma, COPD, chronic allergic rhinitis, or those on inhaled corticosteroids have been excluded from nasal povidone-iodine trials.
Immunodeficiency: The safety and efficacy data comes from people with functional immune systems.

The iodine sensitivity question deserves a brief note. People sometimes confuse iodine allergy with shellfish allergy or contrast-dye allergy, but these are separate things. Allergic reactions to povidone-iodine are typically caused by the povidone carrier or by free iodine’s oxidizing effects on skin or mucosa, and they are uncommon.¹⁶

Does It Affect Your Sense of Smell?

Spraying anything into your nose reasonably raises the question of whether it could harm your sense of smell. Here the evidence is quite reassuring. A randomized trial that tracked olfactory function over 30 days found that smell scores actually improved across all treatment groups, including those using povidone-iodine nasal spray, likely because the patients started with virus-related smell impairment that resolved over time.¹⁴ A separate tolerability study of a liposomal povidone-iodine nasal spray found no clinically relevant changes in olfactory sense, mucosal appearance, or ciliary activity.¹⁷ At appropriate concentrations, povidone-iodine does not appear to damage the olfactory epithelium.

What It Does to the Bacteria Living in Your Nose

Your nasal passages house a diverse community of bacteria, and wiping them out indiscriminately is not necessarily a good thing. Two studies have looked at what povidone-iodine does to this nasal microbiome, and the findings tell a consistent story. Application causes a large, rapid drop in bacterial load, roughly a thousand-fold reduction within five minutes. The species most affected are Cutibacterium acnes, Staphylococcus, and Corynebacterium, all common nasal residents. But the effect is transient: by 24 hours, the bacterial population had largely bounced back.¹⁸

An interesting wrinkle: in surgical patients who received povidone-iodine before their procedure, nasal bacterial diversity was actually higher after surgery than before. That may sound counterintuitive, but it makes sense. If the antiseptic temporarily knocked back dominant species like Staphylococcus, it could open ecological space for other organisms to fill, at least briefly. Staphylococcus specifically trended toward lower relative abundance after treatment.¹⁹ The practical takeaway is that occasional use does not permanently sterilize your nasal flora, but long-term daily use raises questions about chronic microbiome disruption that have not been fully answered yet.

Povidone-Iodine Versus Other Nasal Rinse Options for Chronic Sinus Problems

Some people with chronic rhinosinusitis use medicated sinus rinses to manage recurrent bacterial infections. A study comparing 1 percent povidone-iodine sinus irrigations to mupirocin irrigations and plain saline found that all three approaches produced similar improvements in symptom scores and endoscopic appearance. Culture-negative rates after treatment were numerically highest in the mupirocin group, but the difference was not statistically significant. The povidone-iodine irrigations were very well tolerated and no serious adverse effects were reported.²⁰

This result is actually interesting for what it does not show. Some ear, nose, and throat specialists had hoped that adding povidone-iodine to sinus irrigations would offer a clear advantage over saline alone for chronic sinus patients. The fact that outcomes were roughly equivalent suggests the mechanical flushing action of any sinus rinse may be doing most of the work, with the antiseptic providing at most a marginal additional benefit for chronic conditions. That does not mean povidone-iodine irrigations are useless. For patients harboring antibiotic-resistant bacteria, having a non-antibiotic option that is at least as effective as saline and does not breed further resistance has real value.

Practical Reality of Nasal Iodine Products

Purpose-formulated povidone-iodine nasal sprays exist commercially in some countries. Nasodine, the product used in several of the clinical trials discussed above, is sold over the counter in Australia and has been through Phase II and Phase III clinical testing. In the United States, nasal povidone-iodine is not FDA-approved as a drug for cold or COVID prevention, though some compounding pharmacies prepare it by prescription. You can also find 0.5 to 1 percent povidone-iodine nasal rinse kits marketed for preoperative use in surgical settings.

If you are considering using nasal povidone-iodine on your own, the research points to a few practical guardrails. Stick to concentrations at or below 1.25 percent. Do not dilute Betadine at home unless you can measure accurately, because an error in dilution could leave you with a solution strong enough to damage your nasal cilia. Do not use it if you have thyroid disease, are pregnant, or have a known iodine sensitivity. And keep in mind that even the most optimistic clinical trials suggest the biggest benefit comes from starting early, ideally within the first day of cold symptoms, not after you have been sick for a week. For pre-surgical decolonization, follow whatever protocol your surgical team recommends rather than improvising your own.

1
PubMed Central. Infectious Disease Management and Control with Povidone Iodine
2
PubMed Central. In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2
3
PubMed. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2)
4
PubMed. Phase II Trial of the Impact 0.5% Povidone-Iodine Nasal Spray (Nasodine®) on Shedding of SARS-CoV-2
5
JAMA Otolaryngology–Head & Neck Surgery. Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial
6
PubMed Central. A Pilot Study of 0.4% Povidone-Iodine Nasal Spray to Eradicate SARS-CoV-2 in the Nasopharynx
7
Frontiers in Medicine. Povidone-iodine nasal spray (Nasodine®) for the common cold: a randomized, controlled, double-blind, Phase III clinical trial
8
PubMed. Povidone-Iodine-Based Solutions for Decolonization of Nasal Staphylococcus aureus: A Randomized, Prospective, Placebo-Controlled Study
9
Antimicrobial Stewardship & Healthcare Epidemiology. Preoperative Nasal Povidone Iodine to Prevent Staphylococcus aureus Surgical Site Infections in Pediatric Patients
10
PubMed Central. Preoperative Intranasal Decolonization with Topical Povidone-Iodine Antiseptic and the Incidence of Surgical Site Infection: A Review
11
PubMed. In vitro safety evaluation of a povidone-iodine solution applied to human nasal epithelial cells
12
PubMed. Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era
13
The Journal of Laryngology & Otology. Betadine has a ciliotoxic effect on ciliated human respiratory cells
14
PubMed Central. The Effect of Povidone-Iodine Nasal Spray on Nasopharyngeal SARS-CoV-2 Viral Load: A Randomized Control Trial
15
Journal of Pediatric Endocrinology and Metabolism. Application of povidone-iodine at delivery significantly increases maternal urinary iodine but not neonatal thyrotropin in an area with iodine sufficiency
16
PLOS ONE. Efficacy of “Essential Iodine Drops” against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2)
17
ORL. A Clinical Study on the Tolerability of a Liposomal Povidone-Iodine Nasal Spray: Implications for Further Development
18
PubMed Central. Nasal microbiome and the effect of nasal decolonization with a novel povidone-iodine antiseptic solution: a prospective and randomized clinical trial
19
PLOS ONE. A quality improvement study on the relationship between intranasal povidone-iodine and anesthesia and the nasal microbiota of surgery patients
20
American Journal of Otolaryngology. Tolerability and effectiveness of povidone-iodine or mupirocin versus saline sinus irrigations for chronic rhinosinusitis